Drug shows promise for fighting rare ALS

An experimental drug called tofersen that could help treat a rare kind of ALS is headed to a phase 3 trial.

Tamara Bhandari-Washington University • futurity
July 10, 2020 ~7 min

Tags: als drug-development proteins health-and-medicine medications nerves

‘Ultrafast’ insulin may be 4X speedier than the regular stuff

A new formula for ultrafast insulin could work in much less time than the current stuff, according to research with pigs.

Taylor Kubota-Stanford • futurity
July 2, 2020 ~9 min

Tags: diabetes insulin materials-science polymers drug-development featured health-and-medicine

How cancer drugs find their targets

Certain cancer therapeutics concentrate within cells — a finding that could change the way scientists think about drug design.

Eva Frederick | Whitehead Institute • mit
June 26, 2020 ~10 min

Tags: medicine cancer biology research drug-development school-of-science whitehead-institute koch-institute drug-delivery

Lab-made antibody might block coronavirus infection

A new synthetic antibody may prevent the coronavirus from causing infection by blocking attachment to a key enzyme. It shows promise in a study with mice.

Keith Brannon-Tulane • futurity
June 24, 2020 ~4 min

Tags: covid-19 antibodies viruses drug-development infections health-and-medicine

Experimental peptide targets Covid-19

Computational modeling yields a protein fragment that could bind to coronavirus spike proteins and destroy them.

Anne Trafton | MIT News Office • mit
June 22, 2020 ~6 min

Tags: covid-19 pandemic research drug-development media-lab school-of-architecture-and-planning biological-engineering

Study finds path for addressing Alzheimer’s blood-brain barrier impairment

MIT researchers pinpoint mechanism and demonstrate that drugs could help.

David Orenstein | Picower Institute for Learning and Memory • mit
June 15, 2020 ~7 min

Tags: stem-cells medicine neuroscience alzheimers tissue-engineering research drug-development school-of-science brain-and-cognitive-sciences picower-institute

Could an early antiviral block COVID-19 transmission?

New research on influenza suggests that "the right early-stage antiviral treatment can block transmission to others and, in the long run, may well save more lives."

UT Austin • futurity
June 3, 2020 ~5 min

Tags: influenza covid-19 viruses drug-development health-and-medicine medications

New technology enables fast protein synthesis

Automated tabletop machine could accelerate the development of novel drugs to treat cancer and other diseases.

Anne Trafton | MIT News Office • mit
May 28, 2020 ~8 min

Tags: chemistry medicine research drug-development proteins school-of-science national-science-foundation-nsf

How often do vaccine trials hit paydirt?

Study: Vaccines find more success in development than any other kind of drug, but have been relatively neglected in recent decades.

Peter Dizikes | MIT News Office • mit
May 27, 2020 ~8 min

Tags: medicine public-health covid-19 industry pandemic policy health-care antibiotics vaccines research government drug-development innovation-and-entrepreneurship-ie sloan-school-of-management business-and-management

Antibody from SARS patient blocks coronavirus in lab

The antibody S309, first identified in a blood sample from a recovered SARS patient, inhibits the coronavirus that causes COVID-19, researchers report.

Leila Gray-UW • futurity
May 21, 2020 ~6 min

Tags: covid-19 antibodies sars viruses drug-development featured health-and-medicine

Page 1 of 13